Invitrogen, Active Motif to Collaborate on FPGA-Based Analysis of Sequencing Data | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen and Active Motif said today that they will collaborate in exploring the use of field programmable gate array technology for analyzing next-generation sequencing data.
 
Active Motif markets TimeLogic's biocomputing systems, which couple an FPGA accelerator with optimized genomics algorithms to rapidly compare novel sequences to databases of well-characterized genes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.